Both peptides are capable to increase the pro-inflammatory profile of IBD-derived APC, as demonstrated by the enhanced expression of human leukocyte antigen-DR (HLA-DR) on cDC prompted by peptide B7, which also expanded IL-1β production of B-cells and on pDC by B12. This evidence concerns the gene IL1B and inflammatory bowel disease.